Skip to main content

Open-Label Safety and Tolerability Study of Optimized Doses of NBI-98854 for the Treatment of Pediatric Subjects with Tourette Syndrome

Clinical Trial Grant
Duke Scholars

Administered By

Psychiatry, Child & Family Mental Health & Community Psychiatry

Awarded By

Neurocrine Biosciences, Inc.

Start Date

October 24, 2018

End Date

September 30, 2020
 

Administered By

Psychiatry, Child & Family Mental Health & Community Psychiatry

Awarded By

Neurocrine Biosciences, Inc.

Start Date

October 24, 2018

End Date

September 30, 2020